Cycling with type 1 diabetes: fuelling, monitoring and what riders do

Cycling and type 1 diabetes are not incompatible. They are, however, a genuinely complicated pair, because exercise moves blood glucose in both directions depending on how hard you are going, how much insulin is on board, what you ate, and what you did yesterday. A steady three-hour endurance ride and a hard chaingang produce opposite problems.

Before anything else: this article describes what the published consensus guidance says. It is not medical advice, and it contains no dosing recommendations, because individualised insulin and carbohydrate decisions can only be made by you and your own diabetes team. If you are reading this because you want to start riding seriously, the first step is a conversation with your clinicians about an exercise plan — not a change you make on your own after reading a cycling blog.

What this post can usefully do is explain the mechanisms, so that when your team talks about pre-ride basal reductions or trend arrows, you already understand why. That understanding makes those conversations much shorter and much better.

Why intensity moves glucose in opposite directions

This is the part that confuses people, including people who have had type 1 for years. There is not one exercise response. There are at least two, and they compete.

The competition between those two responses is why a rider can descend into hypoglycaemia during a long steady tempo ride and finish a criterium with glucose higher than when they started. Neither is a mistake. They are different physiological situations, and the published guidance treats them as such.

It also explains one of the more counter-intuitive findings in the literature: a short maximal sprint performed after moderate exercise opposed the post-exercise fall in glucose. That is a real, replicated mechanism — and it is also exactly the sort of finding that should go through your diabetes team rather than being tried out unsupervised on a Saturday.

What the guidance describes as the working tools

Across the major documents — the international consensus statement on exercise management in type 1 diabetes, the EASD and ISPAD position statement on glucose management using CGM, and the American Diabetes Association's position statement on physical activity and diabetes — the same set of levers appears.

CGM on the bike: what it is good at, and where it lags

A sensor on your arm and a number on the stem is a genuine change in what is possible on a bike. It is also not a blood test, and the position statement is direct about the difference.

Interstitial glucose lags blood glucose. When glucose is stable, the lag hardly matters. When it is dropping fast — the second hour of a hard ride, say — the number on the screen describes where you were, not where you are. The guidance describes using the rate of change and the trend arrow as the primary signal during exercise, and confirming with a capillary measurement when the reading and your symptoms disagree.

Practical things riders describe that are consistent with that guidance: mount the display where you can read it without taking a hand off the bars, set alerts with enough margin that you can respond while still riding, and treat a falling arrow as information about the next fifteen minutes rather than the current moment. And carry glucose in a pocket you can reach one-handed, every ride, without exception.

Carbohydrate: the same problem as every cyclist has, with more consequences

Every endurance cyclist has to solve carbohydrate intake for long rides. Type 1 does not change the underlying exercise physiology — muscle still burns glycogen, the gut still has an absorption ceiling, and hourly intake still has to be practised rather than improvised. What changes is that getting it wrong has an immediate and potentially serious consequence rather than just a bad last hour.

The general endurance principles still apply, and are worth knowing well: our pieces on fuelling long rides and training your gut to take 90 g an hour cover intake rates and tolerance. Read them as background on how endurance fuelling works, and then work out the numbers that apply to you with your diabetes team, because the interaction with insulin is the part those articles do not address.

One specific area where the guidance is unambiguous: riding fasted. Fasted training is popular and has a real physiological rationale for some riders, which we discuss in riding fasted. In type 1 diabetes it introduces additional risk and is explicitly a decision for a clinical team. Do not take the general article as applying to you without that conversation.

The overnight problem after a long ride

The risk does not end when the ride does. Muscle continues to replenish glycogen for many hours, insulin sensitivity is increased, and the counter-regulatory response to a falling glucose is blunted after prior exercise.

Research in children with type 1 found that nocturnal hypoglycaemia was considerably more common on nights following an afternoon of exercise than on sedentary control nights. A dedicated consensus statement on post-exercise recovery for endurance athletes with type 1 diabetes addresses this window specifically, alongside the nutrition and monitoring strategies that follow a hard session.

This is the aspect riders most often underestimate, because the ride went well and the problem arrives eight hours later while they are asleep. It is also the aspect where a clinical plan — overnight monitoring, alarm settings, an agreed approach to evening carbohydrate — makes the most difference. It is not something to improvise after your first five-hour day.

Riders who have made it visible

Professional cycling now includes a registered UCI team whose riders all have type 1 diabetes, racing internationally on the road. Elite endurance athletes with type 1 are visible enough that the clinical literature has begun addressing them directly — the post-exercise recovery consensus statement was written specifically for endurance athletes with type 1 diabetes, which tells you how established the population has become.

That visibility is worth something practical as well as symbolic: it establishes that the problem is manageable at the extreme end of endurance sport, which makes a 100 km Sunday ride a considerably less frightening proposition. It does not mean the management is easy, and the riders concerned have full-time medical support that you do not. Treat it as evidence that the ceiling is high, not as a template to copy.

Getting started sensibly

The pattern that appears across the guidance, translated into something a cyclist recognises:

• Start with your team, not with a training plan. Build an exercise plan before you build a training block. The plan should cover a short easy ride, a long endurance ride, and a hard session, because the three behave differently.
• Change one thing at a time. A ride that is longer, harder and at a different time of day than the last one tells you nothing about which change caused what.
• Record everything for the first few months. Ride duration, intensity, what you ate, what happened to glucose during and afterwards. The guidance's whole approach is iterative refinement, and refinement needs data.
• Ride with someone, at first. Particularly for longer rides and for anything remote. Make sure they know you have type 1 and know what to do.
• Build up long rides gradually. A step from two hours to five is a step into a different glucose problem, not just a longer version of the same one. The general advice in how to plan a 200 km ride about incremental long rides applies with extra force here.

The honest summary of the evidence is that exercise in type 1 diabetes is well studied in mechanism and much less well studied in the specific form of multi-hour endurance cycling. The consensus documents themselves acknowledge that much of the practical guidance is built on expert agreement rather than large trials in athletes. That is a reason to work closely with clinicians and to record your own responses carefully — your own data, gathered systematically, is often the best evidence available for your own case.